secwatch.observer — SEC 8-K summary
======================================

Issuer:     RenovoRx, Inc. (RNXT)
CIK:        0001574094
Form:       8-K
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001493152-25-005559
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RenovoRx prices $12.1M underwritten public offering of 11.5M shares at $1.05 per share
--------------------------------------------------------------------------------

- Offering of 11,523,810 shares at $1.05/share; gross proceeds ~$12.1M, net ~$10.9M after underwriting discounts and expenses.
- Closing expected February 10, 2025; underwriter warrants issued for 576,191 shares at $1.21/share.
- Proceeds to fund Phase III TIGeR-PaC study and commercial activities for RenovoCath device.
- Titan Partners Group acted as sole bookrunner for the firm commitment offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574094/000149315225005559/0001493152-25-005559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574094/000149315225005559/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer